PT Folago Global Nusantara Tbk

As of June 30, 2026, PT Folago Global Nusantara Tbk carries a market capitalization of 1.64T, placing it among publicly traded companies globally. Its enterprise value stands at 1.50T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, PT Folago Global Nusantara Tbk has 6.20B shares outstanding.

As of June 30, 2026, PT Folago Global Nusantara Tbk trades at a trailing price-to-earnings ratio of 48.12. The price-to-sales ratio is 2.84, and the price-to-book ratio stands at 5.18.

These figures are as of June 30, 2026. The EV/Sales ratio of 2.57 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 1.50T versus a market cap of 1.64T, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, PT Folago Global Nusantara Tbk maintains a current ratio of 2.20, meaning it holds 2.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.29, indicating conservative leverage, while an interest coverage ratio of 182.68 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, PT Folago Global Nusantara Tbk posted a return on equity (ROE) of 14.47, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) is negative at -4.96, so the business is destroying capital rather than earning a return above its cost of capital. Return on assets (ROA) stands at 10.12, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 10.93, useful for judging operating efficiency across full business cycles. The company generates approximately 29.24B in revenue per employee across its workforce of 20.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 8.49 indicates how many times PT Folago Global Nusantara Tbk sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, PT Folago Global Nusantara Tbk recorded 6.57B in income tax expense. That works out to an effective tax rate of 12.42, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 52.90B, leaving 34.56B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, PT Folago Global Nusantara Tbk's stock has declined approximately 6.84% over the past 52 weeks. The 50-day moving average sits at 356.92, while the 200-day moving average is 420.03.

Over the twelve months ended June 30, 2026, PT Folago Global Nusantara Tbk generated 584.77B in revenue and converted that into 34.56B in net income, yielding earnings per share of 7.36. EBITDA reached -12.55B, while operating income came in at 55.75B.

As of June 30, 2026, PT Folago Global Nusantara Tbk holds 136.79B in cash and equivalents against 905.88M in total debt, resulting in a net debt position of -57.38B. Total book value stands at 315.80B, with working capital of 239.47B providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, PT Folago Global Nusantara Tbk posted a gross margin of 16.63, reflecting its pricing power and cost economics. The operating margin of 9.53 and net profit margin of 5.91 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Total shareholder yield is negative at -6.85, meaning PT Folago Global Nusantara Tbk raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, PT Folago Global Nusantara Tbk has an Altman Z-Score of 7.12, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.